Company: MYGN
Filing Date: 2025-06-05
Form Type: S-8
Source: 0000899923-25-000064
Chunk: 1

Company: MYRIAD GENETICS INC
Filing Date: 2025-06-05
Form: S-8
Chunk 1
---
 for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. [ ]

### EXPLANATORY NOTE
This Registration Statement on Form S-8 registers 6,500,000 additional shares of common stock, par value $0.01 per share (“Common Stock”), for issuance under the Myriad Genetics, Inc. 2017 Employee, Director and Consultant Equity Incentive Plan, as amended (the “Plan”), representing an increase of 6,500,000 shares reserved under the Plan, as approved by the Registrant’s stockholders at the Registrant’s annual meeting of stockholders on June 5, 2025.

This Registration Statement registers additional securities of the same class as other securities for which the registration statements filed on Form S-8 (SEC File Nos. 333-272327, 333-254337, 333-236324, 333-229574 and 333-222913) of the Registrant are effective. The information contained in the Registrant’s registration statements on Form S-8 (SEC File Nos. 333-272327, 333-254337, 333-236324, 333-229574 and 333-222913), except for Item 3 “Incorporation of Documents by Reference”, Item 6 “Indemnification of Directors and Officers” and Item 8 “Exhibits” is hereby incorporated by reference pursuant to General Instruction E of Form S-8.

# PART II

### INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.

The following documents filed by the Registrant with the Commission are incorporated herein by reference:

(a) our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the Commission on February 28, 2025;

(b) our Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 filed with the Commission on May 7, 2025;

(c) our Definitive Proxy Statement on Schedule 14A, filed with the SEC on April 9, 2025 (excluding those portions that are not incorporated by reference into our Annual Report on Form 10-K for the fiscal year ended December 31, 2024); and

(d) our Current Report on Form 8-K as filed with the Commission on February 24, 2025 (other than any portions thereof